Skip to main content

Table 3 The relationship of metabolic syndrome diagnosed by International Diabetes Federation criteria with glycemic control among Type 2 Diabetes patients

From: Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes

Parameters

T2D without MetS (n = 129)

T2D with 3 MetS factors (n = 68)

T2D with 4 MetS factors (n = 146)

T2D with 5 MetS factors (n = 141)

Fasting blood glucose (mmol/l)

7.7 (7.24–8.20)

8.0 (7.33–8.71)

7.9 (7.48–8.39)

8.6 (8.15–9.16)

P-value

0.516

0.526

0.01 (b0.042)

Glycated hemoglobin (%)

7.7 (7.40–8.0)

7.6 (7.18–8.02)

7.6 (7.28–7.83)

8.2 (7.85–8.47)

P-value

0.69

0.507

0.039 (a0.034, b0.005)

C-peptide (pmol/l)

489 (441–542)

569 (493–656)

667 (605–735)

809 (735–893)

P-value

0.096

2.33 × 10−5

1.21 × 10−13 (a7.1 × 10−5, b0.006)

Insulin resistance

2.4 (2.23–2.54)

2.6 (2.39–2.85)

2.9 (2.69–3.03)

3.4 (3.16–3.56)

P-value

0.110

7.65 × 10−5

2.1 × 10−13 (a5.9 × 10−5, b0.0002)

  1. The result presented as geometric mean and 95% confidence interval of mean adjusted to age, sex, race, and history of diabetes
  2. T2D Type 2 Diabetes, MetS metabolic syndrome
  3. aT2D patients with 5 MetS factors versus T2D patients with 3 MetS factors
  4. bT2D patients with 5 MetS factors versus T2D patients with 4MetS factors